These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31889618)

  • 1. Direct in vitro and in vivo demonstration of muscarinic receptor binding by the novel radioligand, [
    Yamada S; Kuraoka S; Ito Y; Kagota S; Shinozuka K; Onoue S
    J Pharmacol Sci; 2020 Mar; 142(3):127-130. PubMed ID: 31889618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of muscarinic receptor binding by the novel radioligand, [(3)H]imidafenacin, in the bladder and other tissues of rats.
    Kuraoka S; Ito Y; Wakuda H; Shinozuka K; Onoue S; Yamada S
    J Pharmacol Sci; 2016 Jul; 131(3):184-9. PubMed ID: 27430986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptor binding of fesoterodine, 5-hydroxymethyl tolterodine, and tolterodine in rat tissues after the oral, intravenous, or intravesical administration.
    Yamada S; Kuraoka S; Ito Y; Kato Y; Onoue S
    J Pharmacol Sci; 2019 May; 140(1):73-78. PubMed ID: 31153768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of bladder selective muscarinic receptor binding by intravesical oxybutynin to treat overactive bladder.
    Oki T; Kimura R; Saito M; Miyagawa I; Yamada S
    J Urol; 2004 Nov; 172(5 Pt 1):2059-64. PubMed ID: 15540789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of muscarinic and nicotinic receptor binding activities of distigmine to treat detrusor underactivity.
    Harada T; Fushimi K; Kato A; Ito Y; Nishijima S; Sugaya K; Yamada S
    Biol Pharm Bull; 2010; 33(4):653-8. PubMed ID: 20410601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fesoterodine, its active metabolite, and tolterodine bind selectively to muscarinic receptors in human bladder mucosa and detrusor muscle.
    Yoshida A; Fuchihata Y; Kuraoka S; Osano A; Otsuka A; Ozono S; Takeda M; Masuyama K; Araki I; Yamada S
    Urology; 2013 Apr; 81(4):920.e1-5. PubMed ID: 23497983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective binding of bladder muscarinic receptors in relation to the pharmacokinetics of a novel antimuscarinic agent, imidafenacin, to treat overactive bladder.
    Yamada S; Seki M; Ogoda M; Fukata A; Nakamura M; Ito Y
    J Pharmacol Exp Ther; 2011 Feb; 336(2):365-71. PubMed ID: 21047953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo demonstration of muscarinic receptor binding activity of N-desethyl-oxybutynin, active metabolite of oxybutynin.
    Oki T; Kawashima A; Uchida M; Yamada S
    Life Sci; 2005 Apr; 76(21):2445-56. PubMed ID: 15763076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of muscarinic cholinergic receptor binding in the vas deferens, bladder, prostate and penis of the rabbit.
    Lepor H; Kuhar MJ
    J Urol; 1984 Aug; 132(2):392-6. PubMed ID: 6737602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic Receptor Binding in Rat Bladder Urothelium and Detrusor Muscle by Intravesical Solifenacin.
    Ito Y; Kashiwabara M; Yoshida A; Hikiyama E; Onoue S; Yamada S
    Biol Pharm Bull; 2016; 39(7):1167-71. PubMed ID: 27374291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic receptor binding of the novel radioligand, [3h]imidafenacin in the human bladder and parotid gland.
    Yoshida A; Kuraoka S; Ito Y; Okura T; Deguchi Y; Otsuka A; Ozono S; Takeda M; Masuyama K; Araki I; Yamada S
    J Pharmacol Sci; 2014; 124(1):40-6. PubMed ID: 24389821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative characterization of lung muscarinic receptor binding after intratracheal administration of tiotropium, ipratropium, and glycopyrrolate.
    Ogoda M; Niiya R; Koshika T; Yamada S
    J Pharmacol Sci; 2011; 115(3):374-82. PubMed ID: 21358117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Excretion Contributes to Long-Lasting Blockade of Bladder Muscarinic Receptors by Imidafenacin: Effect of Bilateral Ureteral Ligation.
    Ito Y; Kuraoka S; Endo S; Takahashi A; Onoue S; Yamada S
    J Pharmacol Exp Ther; 2017 Jan; 360(1):69-74. PubMed ID: 27831487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of nicotinic and muscarinic receptor mRNA in rat bladder by repeated administration of nicotine in relation to the pharmacokinetics.
    Yamamoto N; Yoshida A; Taki Y; Onoue S; Kagawa Y; Yamada S
    Life Sci; 2011 Aug; 89(9-10):343-8. PubMed ID: 21762705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of denervation on muscarinic receptors in the rat bladder.
    Gunasena KT; Nimmo AJ; Morrison JF; Whitaker EM
    Br J Urol; 1995 Sep; 76(3):291-6. PubMed ID: 7551835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic receptor binding characteristics in rat tissues after oral administration of oxybutynin and propiverine.
    Oki T; Yamada S; Tohma A; Kimura R
    Biol Pharm Bull; 2001 May; 24(5):491-5. PubMed ID: 11379767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice.
    Oki T; Maruyama S; Takagi Y; Yamamura HI; Yamada S
    Eur J Pharmacol; 2006 Jan; 529(1-3):157-63. PubMed ID: 16316647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo.
    Hegde SS; Choppin A; Bonhaus D; Briaud S; Loeb M; Moy TM; Loury D; Eglen RM
    Br J Pharmacol; 1997 Apr; 120(8):1409-18. PubMed ID: 9113359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder.
    Stevens LA; Sellers DJ; McKay NG; Chapple CR; Chess-Williams R
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):303-9. PubMed ID: 16879496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of muscarinic receptors in the human bladder mucosa: direct quantification of subtypes using 4-DAMP mustard.
    Yoshida A; Seki M; Nasrin S; Otsuka A; Ozono S; Takeda M; Masuyama K; Araki I; Ehlert FJ; Yamada S
    Urology; 2011 Sep; 78(3):721.e7-721.e12. PubMed ID: 21777958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.